Technology Solutions

Britain’s NHS approves Mytrus e-informed consent

Wednesday, September 9, 2015

Mytrus, a technology and services company working in clinical trials, has announced its software platform for electronic informed consent has received approval for use by Britain’s National Health Service (NHS). It is the first time e-Consent technology will be used in a trial in England.

[Read More]

BioClinica announces eHealth App xChange

Wednesday, September 9, 2015

BioClinica, a specialty clinical trials technology and services provider, has created the eHealth App xChange, an alliance channel for disruptive technology innovation across life sciences and healthcare. BioClinica’s eHealth App xChange provides healthcare payers, providers, researchers, regulators and patients with access to transformative applications integrated with and delivered through BioClinica’s eHealth Cloud.

[Read More]

U.K. approves informed consent technology

Tuesday, September 8, 2015

With a goal of pushing aside paper-based informed clinical trial consents and providing an electronic informed consent system, California-based Mytrus and an unnamed Top 10 pharmaceutical company are set to become the first organizations cleared to use eConsent technology in the U.K.

[Read More]

Greenphire ClinCard System, Duke collaborate

Thursday, August 27, 2015

Greenphire, a King of Prussia, Pa.-based provider of payment technology for the clinical trials industry, has announced that Duke University has selected its ClinCard system to support financial data management and tracking in more than 3,000 clinical studies that the organization conducts each year. As one of the largest biomedical research enterprises in the U.S., Duke will implement Greenphire’s solution to automate the management of payments, and associated data, it makes to research participants annually.

[Read More]

Burning Rock, Illumina collaborate

Wednesday, August 26, 2015

Burning Rock, a Guangzhou, China-based diagnostics company, has entered into an agreement to develop advanced clinical applications for molecular diagnostics in oncology based on Illumina’s next-generation sequencing (NGS) technology. The collaboration highlights the  importance of genomics to improve healthcare in China.

[Read More]

DrugDev hiring in Massachusetts

Monday, August 24, 2015

DrugDev, a health technology company, is putting out a call to SaaS developers in the Boston area to join the team behind a cloud-based software platform that enables clinical trial sponsors, CROs and sites to do more clinical trials together.

[Read More]